Rationale for azithromycin in COVID-19: an overview of existing evidence
Crossref DOI link: https://doi.org/10.1136/bmjresp-2020-000806
Published Online: 2021-01-13
Published Print: 2021-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Gyselinck, Iwein https://orcid.org/0000-0002-4068-7228
Janssens, Wim
Verhamme, Peter
Vos, Robin
License valid from 2021-01-13
